Screening Preeclampsia and the Role of Low Dose Aspirin for the Prevention of Preeclampsia
DOI:
https://doi.org/10.3889/oamjms.2023.11214Keywords:
Low Dose Aspirin, Preeclampsia, PregnancyAbstract
Preeclampsia is one of the leading causes of maternal morbidity and can affect fetal conditions such as inhibition of intrauterine growth, premature labor, placental abruption, fetal distress, and, worst of all, intrauterine fetal death. In contrast to the decreasing incidence of pregnancies with infection, preeclampsia did not decrease significantly during the past two decades. Prevention of preeclampsia is an effort that is currently being intensively carried out to reduce morbidity and mortality of pregnant women. Prophylactic administration of low-dose aspirin (81 mg/day) is recommended in women with a high risk of preeclampsia. It should be started between 12 weeks of gestation to 18 weeks (optimal before 16 weeks). Aspirin has been shown to be safe for the mother and the fetus during pregnancy. Treatment with aspirin also did not increase the risk of developing congenital malformations and had no adverse effect on fetal development or bleeding complications during the neonatal period.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Fox R, Kitt J, Leeson P, Aye CY, Lewandowski AJ. Preeclampsia: Risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J Clin Med. 2019;8(10):1625. https://doi.org/10.3390/jcm8101625 PMid:31590294 DOI: https://doi.org/10.3390/jcm8101625
Obstetri P, Indonesia G. Panduan Nasional Pelayanan Kedokteran (PNPK) Tentang Preeklampsia. Jakarta: Perkumpulan Obstet dan Ginekol Indones; 2015.
Mayrink J, Costa ML, Cecatti JG. Preeclampsia in 2018: Revisiting concepts, physiopathology, and prediction. Sci World J. 2018;2018:6268276. https://doi.org/10.1155/2018/6268276 PMid:30622442 DOI: https://doi.org/10.1155/2018/6268276
Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613-22. DOI: https://doi.org/10.1056/NEJMoa1704559
Sumulyo G, Iswari WA, Pardede TU, Darus F, Puspitasari B, Santana S, et al. Diagnosis dan tatalaksana preeklampsia berat tidak tergantung proteinuria. Cermin Dunia Kedokteran. 2017;44(8):576-9.
Gabbe SG, Niebyl JR, Simpson JL, Landon MB, Galan HL, Jauniaux ER, et al. Obstetrics: Normal and Problem Pregnancies E-book. Netherlands: Elsevier Health Sciences; 2016.
Abdelaziz HK, Saad M, Pothineni NV, Megaly M, Potluri R, Saleh M, et al. Aspirin for primary prevention of cardiovascular events. J Am Coll Cardiol. 2019;73(23):2915-29. https://doi.org/10.1016/j.jacc.2019.03.501 PMid:31196447 DOI: https://doi.org/10.1016/j.jacc.2019.03.501
Atallah A, Lecarpentier E, Goffinet F, Doret-Dion M, Gaucherand P, Tsatsaris V. Aspirin for prevention of preeclampsia. Drugs. 2017;77(17):1819-31. https://doi.org/10.1007/s40265-017-0823-0 PMid:29039130 DOI: https://doi.org/10.1007/s40265-017-0823-0
Guedes-Martins L, Cunha A, Saraiva J, Gaio R, Macedo F, Almeida H. Internal iliac and uterine arteries Doppler ultrasound in the assessment of normotensive and chronic hypertensive pregnant women. Sci Rep. 2014;4(1):3785. https://doi.org/10.1038/srep03785 PMid:24445576 DOI: https://doi.org/10.1038/srep03785
Aardema MW, Saro MC, Lander M, Oosterhof H, Aarnoudse JG. Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: Two different pathophysiological entities. Clin Sci (Lond). 2004;106(4):377-82. https://doi.org/10.1042/CS20030385 PMid:14636154 DOI: https://doi.org/10.1042/CS20030385
Soares S, Fratelli N, Prefumo F, Bhide A, Thilaganathan B. First-trimester uterine artery Doppler and Spontaneous preterm delivery. Ultrasound Obstet Gynecol. 2007;29(2):146-9. https://doi.org/10.1002/uog.3919 PMid:17219368 DOI: https://doi.org/10.1002/uog.3919
Melchiorre K, Wormald B, Leslie K, Bhide A, Thilaganathan B. First-trimester uterine artery Doppler indices in term and preterm preeclampsia. Ultrasound Obstet Gynecol. 2008;32(2):133-7. https://doi.org/10.1002/uog.5400 PMid:18615872 DOI: https://doi.org/10.1002/uog.5400
Kim J, Lee KS, Kim JH, Lee DK, Park M, Choi S, et al. Aspirin prevents TNF-α-induced endothelial cell dysfunction by regulating the NF-κb- dependent mir-155/eNOS pathway: Role of a mir-155/eNOS axis in preeclampsia. Free Radic Biol Med. 2017;104:185-98. https://doi.org/10.1016/j.freeradbiomed.2017.01.010 PMid:28087411 DOI: https://doi.org/10.1016/j.freeradbiomed.2017.01.010
Porter TF, Gyamfi-Bannerman C, Manuck T. Low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44-52. https://doi.org/10.1097/AOG.0000000000002708 PMid:29939940 DOI: https://doi.org/10.1097/AOG.0000000000002708
Vieillefosse S, Guibourdenche J, Atallah A, Haddad B, Fournier T, Tsatsaris V, et al. Predictive and prognostic factors of preeclampsia: Interest of PLGF and sFLT-1. J Gynecol Obstet Biol Reprod (Paris). 2016;45(9):999-1008. https://doi.org/10.1016/j.jgyn.2016.02.006 PMid:27212611 DOI: https://doi.org/10.1016/j.jgyn.2016.02.006
Lin L, Zhu Y, Li B, Yang H. Low-dose aspirin in the prevention of pre-eclampsia in China (APPEC study): Protocol for a multicentre randomized controlled trial. Trials. 2018;19(1):608. https://doi.org/10.1186/s13063-018-2970-3 PMid:30400937 DOI: https://doi.org/10.1186/s13063-018-2970-3
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Wayan Artana Putra (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0